Anti-Aging · Reference
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
This page sets out what each line of MOTS-c research measured and over what period, why that does not convert into days or weeks for you, how MOTS-c is taken at Pepti, and what to track. For the molecule itself, read what is MOTS-c.
Treatments mentioned
No one can tell you how long MOTS-c takes to work, because there are no randomised controlled trials of MOTS-c in people. The treatment evidence is in mice: the 2015 Cell Metabolism work on insulin resistance and high-fat-diet weight gain, a 2019 study in ovariectomised mice, and a 2021 Nature Communications paper on physical capacity, including intermittent treatment started late in life. The human data is observational, measuring the body's own MOTS-c, plus a four-week company-reported study of a modified analogue, CB4211, which is a different molecule. None of that is a timeline for a person injecting MOTS-c.
This page sets out what each line of MOTS-c research measured and over what period, why that does not convert into days or weeks for you, how MOTS-c is taken at Pepti, and what to track. For the molecule itself, read what is MOTS-c.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
The short answer
| Research | Who or what | Period | What it measured |
|---|---|---|---|
| Cell Metabolism, 2015 | Mice | Treatment during ageing or a high-fat diet | Insulin resistance and weight gain, both reported prevented |
| Journal of Molecular Medicine, 2019 | Ovariectomised mice | Treatment period of the model | Fat accumulation and brown-fat activity |
| Biochemical and Biophysical Research Communications, 2016 | Ovariectomised mice and cells | Treatment period of the model | Bone loss on micro-CT |
| Nature Communications, 2021 | Young, middle-aged and old mice | Including intermittent treatment started very late in life | Physical performance and healthy lifespan |
| Nature Communications, 2021 | Humans | A single bout of exercise | The body's own MOTS-c in muscle and blood, which rose |
| CB4211 Phase 1b, company-reported 2021 | 20 adults with obesity and fatty liver disease | Once-daily injections for four weeks | Safety and tolerability; exploratory liver enzymes and glucose |
| Human trials of MOTS-c | None | None | Nothing has been measured |
The only human dosing study on the list is of a different molecule, it was not peer-reviewed, and its programme did not advance beyond Phase 1.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
Why there is no timeline for MOTS-c
| The gap | What the research did | What a MOTS-c prescription involves |
|---|---|---|
| Species | Mice for every treatment effect | People |
| Molecule | MOTS-c in mice; CB4211, an analogue, in the one human dosing study | Compounded MOTS-c |
| Human data | The body's own MOTS-c measured after exercise or in people with and without diabetes | Injected MOTS-c |
| Endpoint | Insulin resistance, fat gain, treadmill performance, bone on micro-CT | Whatever you are hoping changes |
The human observational studies describe what the body does, not what an injection does. A 2021 study in Aging tied a mitochondrial DNA variant that changes MOTS-c to type 2 diabetes in men, and a 2019 Qatar study reported lower serum MOTS-c in type 2 diabetes. Other observational studies do not line up neatly. Raising MOTS-c by injection has not been shown to do what naturally higher levels correlate with, and no study has measured how long that would take. More is in MOTS-c benefits.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
What each line of research tells you about timing
Mouse metabolic studies
In the founding 2015 Cell Metabolism work, MOTS-c treatment in mice was reported to prevent age-related insulin resistance and the insulin resistance and weight gain that develop on a high-fat diet. These are prevention findings in mice over the course of the model, not changes in an adult who already has a problem. The 2019 ovariectomised-mouse study reported less fat accumulation and more brown-fat activity. MOTS-c is not a weight-loss drug, and no human trial shows weight loss from it. If weight is the goal, MOTS-c vs tirzepatide and MOTS-c vs semaglutide set out the difference in evidence.
Physical capacity and late life
The 2021 Nature Communications paper reported better physical performance in mice of every age, and that intermittent treatment started very late in life was associated with better physical capacity and longer healthy lifespan. The intermittent dosing in that work is one reason prescribers describe a five-days-on, two-off schedule, though that schedule is a prescribing convention rather than something derived from a trial. The human part of the same paper measured the body's own MOTS-c rising after exercise. It did not give anyone MOTS-c.
The four-week analogue study
CohBar ran a Phase 1a in 65 healthy adults and then a randomised, placebo-controlled Phase 1b of its analogue CB4211, with once-daily subcutaneous injections for four weeks in 20 adults with obesity and fatty liver disease. The company reported in 2021 that the safety and tolerability endpoint was met with no serious adverse events, and described lower liver enzymes and glucose on exploratory endpoints. That is the closest thing to a human treatment timeline in this area, and it is a company announcement about a different molecule.
Energy
No study has measured energy or fatigue in people given MOTS-c. Fatigue is the complaint most likely to have a treatable cause such as thyroid, iron, sleep apnoea, low mood or a medication, and those deserve attention first. See peptides for energy and fatigue.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
How MOTS-c is taken at Pepti
| Question | Answer |
|---|---|
| Product | MOTS-c |
| Vial | 5 mL multi-dose vial, 2 mg/mL (10 mg per vial) |
| Typical directions | Inject 0.25 mL (25 units) subcutaneously Monday through Friday mornings |
| Per dose | 0.5 mg |
| Doses per vial | 20, about four weeks |
| Pen | 3 mL pre-filled Pen cartridge containing 30 mg MOTS-c, dosed by dial as printed with your prescription |
| Price | $259/mo, all-in |
MOTS-c also appears in the PHYSIQ ($289/mo), SHRED ($279/mo), FUSION ($279/mo), EUPHORIA ($279/mo) and SYNAPSE ($279/mo) blends. No study has tested MOTS-c in combination with anything.
Your physician sets your directions after reviewing your intake, and they are printed on the vial. The morning timing places the dose near the day's activity. The units and mL detail is in MOTS-c dosage. Prices cover medication, physician review, refill management and shipping, with no separate membership fee. Vials ship refrigerated with ice packs, ready to use, with sterile syringes and alcohol prep pads, and refills run every 28 days, one vial per fill.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
While you are on it
| What to do | Why |
|---|---|
| Take it on the schedule printed on the vial | Weekends off are part of the directions |
| Keep training and nutrition going | Prescribers describe MOTS-c as something taken alongside a plan, not instead of one |
| Note the specific thing you hope changes | With no trial timeline, your own record is the most useful information at refill |
| Tell your care team about anything that lowers blood glucose | The described mechanism is insulin sensitivity |
| Message your care team about side effects | Injection-site redness, and transient jitteriness, a faster pulse or light-headedness in the hour or two after a morning dose, are what is reported |
| Do not change your own dose | More is not a way to make it work sooner |
For a reaction that is severe, spreading, or involves difficulty breathing, stop and call 911 or go to an emergency department, then tell your physician. The fuller list is in MOTS-c side effects.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
What the evidence does not establish
- That injected MOTS-c changes weight, glucose, fitness or lifespan in people.
- An effect size or a timeline; anything said about "results in X weeks" is prescriber experience or extrapolation from mice.
- That raising MOTS-c by injection does what naturally higher levels correlate with.
- That CB4211 results apply to MOTS-c.
- Long-term safety over years of use.
When the FDA's reviewers assessed MOTS-c for the July 2026 advisory committee, they recommended against adding it to the 503A Bulks List, citing the absence of human clinical data; the committee voted 7 to 5, with two abstentions, to recommend adding it anyway, for obesity and osteoporosis. The FDA's final determination is pending. MOTS-c was removed from Category 2 of the interim 503A list on 15 April 2026 and remains legal to prescribe. It is not FDA approved, and compounded medications are not FDA approved. MOTS-c is on the WADA Prohibited List at all times as an AMPK activator. The cross-category picture is in how long do peptides take to work.
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period
Where to get MOTS-c prescribed
MOTS-c cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and side effects.
Step by step: how to get MOTS-c prescribed online. Comparisons: MOTS-c vs tesamorelin and MOTS-c vs SLU-PP-332 vs 5-Amino-1MQ.
References
What this is based on.
References
- Lee C, Zeng J, Drew BG et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance · Cell Metab (2015) · PMID 25738459
- Reynolds JC, Lai RW, Woodhead JST et al.. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis · Nat Commun (2021) · PMID 33473109
- Kim KH, Son JM, Benayoun BA et al.. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress · Cell Metab (2018) · PMID 29983246
- Zempo H, Kim SJ, Fuku N et al.. A pro-diabetogenic mtDNA polymorphism in the mitochondrial-derived peptide, MOTS-c · Aging (Albany NY) (2021) · PMID 33468709
- Ramanjaneya M, Bettahi I, Jerobin J et al.. Mitochondrial-Derived Peptides Are Down Regulated in Diabetes Subjects · Front Endocrinol (Lausanne) (2019) · PMID 31214116
- Cataldo LR, Fernández-Verdejo R, Santos JL et al.. Plasma MOTS-c levels are associated with insulin sensitivity in lean but not in obese individuals · J Investig Med (2018) · PMID 29593067
- Lu H, Wei M, Zhai Y et al.. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction · J Mol Med (Berl) (2019) · PMID 30725119
- Ming W, Lu G, Xin S et al.. Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation · Biochem Biophys Res Commun (2016) · PMID 27237975
- Knoop A, Thomas A, Thevis M. Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes · Rapid Commun Mass Spectrom (2019) · PMID 30394592
- Ozkaya DY, Haymana C, Demirci I et al.. MOTS-C levels in individuals with and without obesity and its association with inflammation, insulin resistance and endothelial dysfunction · Arch Endocrinol Metab (2025) · PMID 41004666
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
How Long Does MOTS-c Take to Work? What the Research Measured, and Over What Period, answered.
That has not been measured in people. There are no human trials of MOTS-c. The treatment research is in mice, and the one human dosing study, four weeks of a modified analogue called CB4211, was company-reported and tested a different molecule.
No human trial shows weight loss from MOTS-c. The mouse finding was prevention of weight gain on a high-fat diet, not loss of fat already there. MOTS-c is not a weight-loss drug.
No study has measured energy or fatigue in people given MOTS-c. Some people describe a change during training and others notice nothing, which prescribers describe as normal.
Some people report transient jitteriness, a faster pulse or mild light-headedness in the hour or two after a morning dose, mostly early in a course. That is a side effect, not a sign of how it is working. Tell your care team if it does not settle.
There is no trial-based number. A vial covers about four weeks of weekday doses, and you can raise how it is going with your care team at any time, including at refill.
The intermittent treatment in the 2021 mouse work is one reason prescribers describe a five-days-on, two-off schedule. That schedule is a prescribing convention, not something derived from a human trial.
Nothing shows that. No study has tested MOTS-c in combination with anything. A blend is a convenience, and it makes it harder to tell which component did what.
No. Take the dose printed on your vial on the schedule printed on your vial. If you have questions about your directions, message your care team.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.